Review




Structured Review

Tempero Pharmaceuticals microarray data analyses
Microarray Data Analyses, supplied by Tempero Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray data analyses/product/Tempero Pharmaceuticals
Average 90 stars, based on 1 article reviews
microarray data analyses - by Bioz Stars, 2026-03
90/100 stars

Images



Similar Products

99
Thermo Fisher dna rna microarray data analyses
Protein candidates proposed as potential prognostic markers for high and low risk of tumour recurrence in CRC-II patients.
Dna Rna Microarray Data Analyses, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/dna rna microarray data analyses/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
dna rna microarray data analyses - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier

90
CapitalBio Corporation microarray data analyses
Protein candidates proposed as potential prognostic markers for high and low risk of tumour recurrence in CRC-II patients.
Microarray Data Analyses, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray data analyses/product/CapitalBio Corporation
Average 90 stars, based on 1 article reviews
microarray data analyses - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Genotypic Technology Pvt Ltd microarray experiments and data analyses
Protein candidates proposed as potential prognostic markers for high and low risk of tumour recurrence in CRC-II patients.
Microarray Experiments And Data Analyses, supplied by Genotypic Technology Pvt Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray experiments and data analyses/product/Genotypic Technology Pvt Ltd
Average 90 stars, based on 1 article reviews
microarray experiments and data analyses - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Arraystar inc microarray data analyses
Protein candidates proposed as potential prognostic markers for high and low risk of tumour recurrence in CRC-II patients.
Microarray Data Analyses, supplied by Arraystar inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray data analyses/product/Arraystar inc
Average 90 stars, based on 1 article reviews
microarray data analyses - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
CapitalBio Corporation microarray procedures and data analyses
Protein candidates proposed as potential prognostic markers for high and low risk of tumour recurrence in CRC-II patients.
Microarray Procedures And Data Analyses, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray procedures and data analyses/product/CapitalBio Corporation
Average 90 stars, based on 1 article reviews
microarray procedures and data analyses - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
AltraBio Inc microarray data analyses
Protein candidates proposed as potential prognostic markers for high and low risk of tumour recurrence in CRC-II patients.
Microarray Data Analyses, supplied by AltraBio Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray data analyses/product/AltraBio Inc
Average 90 stars, based on 1 article reviews
microarray data analyses - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

86
Thermo Fisher microarray data analyses
Protein candidates proposed as potential prognostic markers for high and low risk of tumour recurrence in CRC-II patients.
Microarray Data Analyses, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray data analyses/product/Thermo Fisher
Average 86 stars, based on 1 article reviews
microarray data analyses - by Bioz Stars, 2026-03
86/100 stars
  Buy from Supplier

90
Genotypic Technology Pvt Ltd microarray processing and data analyses
Protein candidates proposed as potential prognostic markers for high and low risk of tumour recurrence in CRC-II patients.
Microarray Processing And Data Analyses, supplied by Genotypic Technology Pvt Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray processing and data analyses/product/Genotypic Technology Pvt Ltd
Average 90 stars, based on 1 article reviews
microarray processing and data analyses - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Tempero Pharmaceuticals microarray data analyses
Protein candidates proposed as potential prognostic markers for high and low risk of tumour recurrence in CRC-II patients.
Microarray Data Analyses, supplied by Tempero Pharmaceuticals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/microarray data analyses/product/Tempero Pharmaceuticals
Average 90 stars, based on 1 article reviews
microarray data analyses - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Protein candidates proposed as potential prognostic markers for high and low risk of tumour recurrence in CRC-II patients.

Journal: BJC Reports

Article Title: Protein prognostic biomarkers in stage II colorectal cancer: implications for post-operative management

doi: 10.1038/s44276-024-00043-z

Figure Lengend Snippet: Protein candidates proposed as potential prognostic markers for high and low risk of tumour recurrence in CRC-II patients.

Article Snippet: Candidate selection can be made via informatics approaches [ , ], DNA/RNA microarray data analyses [ ], protein involvement in key biochemical processes [ ], being differentially expressed through mass spectrometry (MS) analysis [ ], Olink proteomics assays [ ] or SomaLogic assays [ ] or as a diagnostic or prognostic marker for other tumour types [ ].

Techniques: Biomarker Discovery, Expressing, Marker, Reverse Transcription Polymerase Chain Reaction, Microarray, Over Expression